Alphatec Holdings Announces Appointment of Patrick Ryan as Chief Operating Officer
25 April 2011 - 3:15PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures, and markets products for the surgical
treatment of spine disorders, with a focus on treating conditions
related to the aging spine, today announced the appointment of
Patrick Ryan as the Company's Chief Operating Officer.
Mr. Ryan joins the Company from Abbott Vascular Devices, where
he has been the Vice President, North Asia since August 2010. This
division of Abbott Vascular has annual revenues of $200
million. For the two years prior to his role in North Asia, he
served as Abbott Vascular's Divisional Vice President for Canada
and Latin America. Prior to that position, Mr. Ryan held two
senior roles in Operations, specifically, Divisional Vice
President, Worldwide Operations and Divisional Vice President,
Operations, Cardiac Therapies. Before joining Abbott, Mr. Ryan
held several positions with Guidant Corporation, including Vice
President and Managing Director, Guidant Ireland. Prior to
joining Guidant, Mr. Ryan served 14 years in the United States
Navy, earning the rank of Commander. He received his MS in
Petroleum Management from University of Kansas and his BS, from the
United States Naval Academy.
Dirk Kuyper, the Company's President and Chief Executive
Officer, stated, "We are extremely excited to welcome a
professional of Pat Ryan's caliber to Alphatec Spine's management
team. Pat's years of senior-level leadership on a global scale in
the medical device industry will allow him to rapidly add value as
our COO."
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec
Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device
company that designs, develops, manufactures and markets products
for the surgical treatment of spine disorders, primarily focused on
the aging spine. The Company's mission is to combine world-class
customer service with innovative, surgeon-driven design that will
help improve the aging patient's quality of life. The Company is
poised to achieve its goal through new solutions for patients with
osteoporosis, stenosis and other aging spine deformities, improved
minimally invasive products and techniques and integrated biologics
solutions. In addition to its U.S. operations, the Company also
markets its products in over 50 international markets through its
subsidiary, Scient'x S.A.S., via a direct sales force in France,
Italy and the United Kingdom and via independent distributors in
the rest of Europe, the Middle East and Africa, South America and
Latin America. In Asia and Australia, the Company markets its
products through its subsidiary, Alphatec Pacific, Inc, and through
Scient'x's distributors in China, Korea and Australia.
Also visit the Aging Spine Center, a web-based information
portal for healthcare providers and patients regarding aging spine
disorders and their treatment. Alphatec Spine is working with the
National Osteoporosis Foundation as well as other clinical portals
that provide peer-reviewed content, to populate the Aging Spine
Center. The interactive website will enable patients to review
pertinent information about all the key disorders that affect the
aging spine in an easy-to-understand format that includes videos,
graphics and questions that should be asked of caregivers. Medical
information will include published abstracts regarding the aging
spine.
The Alphatec Holdings, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3520
Forward Looking Statements
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainty. Such statements are
based on management's current expectations and are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. Please refer to the risks detailed from time to time in
Alphatec Spine's SEC reports, including quarterly reports on Form
10-Q, reports on Form 8-K and annual reports on Form 10-K. Alphatec
Spine disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise, unless required by law.
CONTACT: Michael O'Neill
Chief Financial Officer
Alphatec Spine, Inc.
(760) 494-6746
investorrelations@alphatecspine.com
Westwicke Partners
Lynn C. Pieper
(415) 202-5678
lynn.pieper@westwicke.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Sep 2024 bis Okt 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Okt 2023 bis Okt 2024